Galderma (SIX: GALD), the pure-play dermatology category leader, has announced the launch of Restylane Defyne and Restylane Refyne: the first OBT‑based hyaluronic acid injectables ever authorized in ...

Hyaluronic acid 20mg/mL, lidocaine 3mg/mL; injectable gel implant. Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to ...

There's a new filler in town (actually, two new fillers) and they're billed as the next big thing in the fight against laugh lines. Galderma, the pharmaceutical company behind injectables like ...

Galderma, the brand behind fillers like Restylane, Dysport and Sculptra Aesthetic, announced today the FDA approval of two new fillers to the Restylane category: Restylane Refyne and Restylane Defyne.

Please provide your email address to receive an email when new articles are posted on . Galderma announced it has received FDA approval of two new Restylane products for the treatment of nasolabial ...

Millions of Americans have had their lips plumped and wrinkles smoothed with injectable fillers. But many complain facial expressions don't always look natural. Now two new entries in the filler ...

This expands Galderma’s Restylane portfolio in Japan to four products, enabling treatment of a wider spectrum of patient and practitioner needs 3,4 These two new launches underscore Galderma’s ...

Restylane Refyne and Restylane Defyne are the first Optimal Balance Technology (OBT) hyaluronic acid injectables ever approved and launched in Japan, bringing advanced flexibility and natural movement ...